Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Enoxaparin versus unfractionated heparin: consequences of treatment duration on efficacy and safety in SYNERGY

Enoxaparin versus unfractionated heparin: consequences of treatment duration on efficacy and safety in SYNERGY. Journal of the American College of Cardiology. 2005; 45(Suppl1):247A.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.